Trials / Completed
CompletedNCT01566760
A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers
Open-Label, Single-Dose, Randomized, Crossover Study To Estimate The Effects Of Food On The Pharmacokinetics Of Two Fesoterodine Sustained-Release Beads-In-Capsule Formulations And To Estimate The Relative Bioavailability Of One Or Both Formulations Compared To Commercial Tablet Formulation In Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 2-cohort, 3-period study to characterize the pharmacokinetics (process by which drug fesoterodine is absorbed, distributed, metabolized, and eliminated by the body) and the effects of food on the pharmacokinetics of the drug. This study will take place over approximately 8 weeks and will consist of a screening visit to determine eligibility for the study, and 2- or 3-period treatment phase for each cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fesoterodine fumarate | One capsule of 4 mg PF-00695838 Formulation SR1 under fasting conditions, single dose |
| DRUG | fesoterodine fumarate | One capsule of 4 mg PF-00695838 Formulation SR2 under fasting conditions, single dose |
| DRUG | fesoterodine fumarate | One capsule of 4 mg PF-00695838 Formulation SR1 under fed conditions, single dose |
| DRUG | fesoterodine fumarate | One capsule of 4 mg PF-00695838 Formulation SR2 under fed conditions, single dose |
| DRUG | fesoterodine fumarate | one extended-release tablet of commercially available fesoterodine fumarate 4 mg under fasting conditions, single dose |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-03-29
- Last updated
- 2016-08-19
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT01566760. Inclusion in this directory is not an endorsement.